Previous Close | 0.7302 |
Open | 0.6700 |
Bid | 0.6666 x 0 |
Ask | 0.6796 x 0 |
Day's Range | 0.6700 - 0.6700 |
52 Week Range | 0.6700 - 5.8500 |
Volume | |
Avg. Volume | 166 |
Market Cap | 42.291M |
Beta (5Y Monthly) | 2.12 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of 16.67% and 20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Immatics (IMTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Celebrations may be in order for Syros Pharmaceuticals, Inc. ( NASDAQ:SYRS ) shareholders, with the analysts delivering...